Vera Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vera Therapeutics generated cash of -$92,181,000, which is less than the previous year. Cash used in financing activities reached the amount of $133,541,000 last year. Net change in cash is therefore $1,929,000.
Cash Flow
| 2019 | -10.28M | -125K | -137K |
|---|---|---|---|
| 2020 | -34.80M | -42K | 85.29M |
| 2021 | -23.70M | -4.20M | 53.88M |
| 2022 | -67.59M | -70.55M | 101.93M |
| 2023 | -92.18M | -39.43M | 133.54M |
VERA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 43.75M | 79.96M | 53.99M | 3.55M | 14.10M |
Operating activities | |||||
Net income | -95.99M | -89.05M | -32.60M | -53.41M | -11.85M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | -4.08M | -846K | 176K | 251K | 509K |
Stock-based compensation expense | 11.49M | 8.88M | 3.01M | 331K | 263K |
| Deferred income tax benefit | 11.49M | 8.88M | 3.01M | 331K | 263K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 159K |
Inventories | 0 | 0 | 0 | 0 | -159K |
Accounts payable | -873K | 10.60M | 475K | 567K | -291K |
Cash generated by operating activities | -92.18M | -67.59M | -23.70M | -34.80M | -10.28M |
Investing activities | |||||
Purchases Of Investments | -224.93M | -148.49M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -63K | -62K | 0 | -99K | -125K |
Acquisitions Net | 0 | 70.49K | 796K | 57K | 0 |
Cash generated by investing activities | -39.43M | -70.55M | -4.20M | -42K | -125K |
Financing activities | |||||
Common Stock Issued | 115M | 86.13M | 51.17M | 79.84M | 51K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 24.74M | 19.81M | -4.92M | -130K | -188K |
Cash used in financing activities | 133.54M | 101.93M | 53.88M | 85.29M | -137K |
Net Change In Cash | 1.92M | -36.21M | 25.97M | 50.43M | -10.55M |
Cash at end of period | 45.68M | 43.75M | 79.96M | 53.99M | 3.55M |
| Data source | Data source | Data source |